Title: Commentary: A promising gene therapy approach to treat disc degeneration
Abstract: COMMENTARY ON Leckie SK, Bechara BP, Hartman RA, et al. Injection of AAV2-BMP-2 and AAV2-TIMP-1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine J 2012;12:7–20 (in this issue). Leckie SK, Bechara BP, Hartman RA, et al. Injection of AAV2-BMP-2 and AAV2-TIMP-1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine J 2012;12:7–20 (in this issue). Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit modelThe Spine JournalVol. 12Issue 1PreviewIntervertebral disc degeneration (IDD) is a common cause of back pain. Patients who fail conservative management may face the morbidity of surgery. Alternative treatment modalities could have a significant impact on disease progression and patients’ quality of life. Full-Text PDF
Publication Year: 2012
Publication Date: 2012-01-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 4
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot